Short-term low-dose heparin plus bedrest impairs bone metabolism in pregnant women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 106, Issue 1, 2003, Pages 25-30

  Von Mandach, Ursula ^a   Aebersold, Franziska ^a   Huch, Renate ^a   Huch, Albert ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

1,25 Dihydroxyvitamin D 3; Bedrest; Heparin; Osteoporosis; Pregnancy

Indexed keywords

CALCITRIOL; CALCIUM ION; CREATININE; HEPARIN; OSTEOCALCIN; CALCIUM;

ADULT; ARTICLE; BED REST; BONE METABOLISM; CALCIUM BLOOD LEVEL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; OSTEOPOROSIS; PLACENTA PREVIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; BLOOD; BONE; BONE DENSITY; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; METABOLISM; PREGNANCY COMPLICATION;

BED REST; BONE AND BONES; BONE DENSITY; CALCIUM; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPARIN; HUMANS; OSTEOCALCIN; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 0037427576     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00200-2     Document Type: Article

References (20)

1. Aarskog D., Aksnes L., Markestad T., Ulstein M., Sagen N. Heparin-induced inhibition of 1,25-dihydroxyvitamin D formation. Am. J. Obstet. Gynecol. 148:1984;1141-1142.
2. Dahlman T., Sjoberg H.E., Hellgren M., Bucht E. Calcium homeostasis in pregnancy during long-term heparin treatment. Br. J. Obstet. Gynaecol. 99:1992;412-416.
3. Haram K., Hervig T., Thordarson H., Aksnes L. Osteopenia caused by heparin treatment in pregnancy. Acta Obstet. Gynecol. Scand. 72:1993;674-675.
4. Barbour L.A., Kick S.D., Steiner J.F.et al. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am. J. Obstet. Gynecol. 170:1994;862-869.
5. Wise P.H., Hall A.J. Heparin-induced osteopenia in pregnancy. Br. Med. J. 281:1980;110-111.
6. Seki K., Makimura N., Mitsuic C., Hirata J., Nagata I. Calcium-regulating hormones and osteocalcin levels during pregnancy: a longitudinal study. Am. J. Obstet. Gynecol. 164:1991;1248-1252.
7. Cross N.A., Hillman L.S., Allen S.H., Krause G.F., Vieira N.E. Calcium homeostasis and bone metabolism during pregnancy, lactation and postweaning: a longitudinal study. Am. J. Clin. Nutr. 61:1995;514-523.
8. Seely E.W., Brown E.M., De Maggio D.M., Weldon D.K., Graves S.W. A prospective study of calciotropic hormones in pregnancy and post partum: reciprocal changes in serum intact parathyroid hormone and 1,25-dihydroxyvitamin D. Am. J. Obstet. Gynecol. 176:1997;214-217.
9. Dambacher M.A., Ruegsegger P. Bone density measurements and their indications. Orthopade. 23:1994;38-44.
10. Bowers G.N., Brassard C., Sena S.F. Measurement of ionized calcium in serum with ion-selective electrodes: a mature technology that can meet the daily service needs. Clin. Chem. 32:1986;1437-1447.
11. Burtis CA, Ashwood ER, Endres DB, Rude RK. Tietz Textbook of Clinical Chemistry. 2nd Ed. Philadelphia, PA: W.B. Saunders Company; 1994.
12. Fraser W.D., Durham B.H., Berry J.L., Mawer E.B. Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann. Clin. Biochem. 34:1997;632-637.
13. Minisola S., Rosso R., Romagnoli E.et al. Serum osteocalcin and bone mineral density at various skeletal sites: a study performed with three different assays. J. Lab. Clin. Med. 129:1997;422-429.
14. Baker P.N., Hackett G.A. The use of urinary albumin-creatinine ratios and calcium-creatinine ratios as screening tests for pregnancy-induced hypertension. Obstet. Gynecol. 83:1994;745-749.
15. Bonini P., Ceriotti F., Keller F.et al. Multicentre evaluation of the Boehringer Mannheim/Hitachi 747 analysis system. Eur. J. Clin. Chem. Clin. Biochem. 30:1992;881-899.
16. Gallacher S.J., Fraser W.D., Owens O.J.et al. Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur. J. Endocrinol. 131:1994;369-374.
17. Reid I.R., Wattie D.J., Evans M.C., Budayr A.A. Post-pregnancy osteoporosis associated with hypercalcaemia. Clin. Endocrinol. (Oxf.). 37:1992;298-303.
18. van der Vijgh W.J.F., Kruik A.J.B., Jongen M.J.M., Lips P., Netelenbos J.C. Inhibition of 25(OH)D 1α-hydroxylase in kidney homogenates of Japanese quails by heparin. Calcif. Tissue Int. 35(Suppl):1983;50.
19. Mätzsch T., Bergqvist D., Hedner U., Nilsson B., Ostergaard P. Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats. Thromb. Haemost. 63:1990;505-509.
20. Kohlmeier L., Marcus R. Calcium disorders of pregnancy. Endocrinol. Metab. Clin. North Am. 24:1995;15-39.